A Sydney doctor, who wishes to remain anonymous, has sent in the following piece examining the complexities of conflict of interest issues. It’s timely in view of the approaching NHMRC workshop on this issue, and recent debate surrounding Vioxx promotions, industry sponsored guidelines for DVT prevention, and the Baker/Sanofi deal, amongst other things.
The doctor writes:
It’s [...]